Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/MEAI> ?p ?o }
Showing triples 1 to 63 of
63
with 100 triples per page.
- MEAI abstract "5-Methoxy-2-aminoindane (MEAI, also known as 5-MeO-AI), also called Chaperon, is a psychoactive small molecule belonging to the aminoindanes with a mechanism of action described by one patent as dopamine D3 receptor ligands.It was first prepared by Schering AG in 1956. David Nutt and Amanda Feilding filed a patent application for the drug that is supposed to give people a pleasant intoxication as well as limit the amount they drink.MEAI was available through grey market sources in 2011. At least 2 journalists tried it on themselves and reported to the public: Michael Slezak from New Scientist and Brie Traits from BBC3.Apparently, Nutt has also tried it himself.The idea of alcohol substitution got public attention 1 year prior to the announcement of chaperon but apparently, chaperon innovates in that it can be consumed together with alcohol without ill effect.".
- MEAI atcPrefix "none".
- MEAI casNumber "73305-09-6".
- MEAI iupacName "5-Methoxy-2-indanamine".
- MEAI pubchem "12147687".
- MEAI thumbnail 5-Methoxy-2-indanamine.svg?width=300.
- MEAI wikiPageID "14278124".
- MEAI wikiPageLength "4699".
- MEAI wikiPageOutDegree "13".
- MEAI wikiPageRevisionID "680657358".
- MEAI wikiPageWikiLink 1-Aminomethyl-5-methoxyindane.
- MEAI wikiPageWikiLink 2-AI.
- MEAI wikiPageWikiLink 2-Aminoindane.
- MEAI wikiPageWikiLink Amanda_Feilding.
- MEAI wikiPageWikiLink Category:Amines.
- MEAI wikiPageWikiLink Category:Designer_drugs.
- MEAI wikiPageWikiLink Category:Drugs_with_unknown_mechanisms_of_action.
- MEAI wikiPageWikiLink Category:Indanes.
- MEAI wikiPageWikiLink David_Nutt.
- MEAI wikiPageWikiLink Dopamine_D3.
- MEAI wikiPageWikiLink Dopamine_receptor_D3.
- MEAI wikiPageWikiLink MDAI.
- MEAI wikiPageWikiLink MMAI.
- MEAI wikiPageWikiLink NM-2-AI.
- MEAI wikiPageWikiLink Schering_AG.
- MEAI wikiPageWikiLinkText "MEAI".
- MEAI atcPrefix "none".
- MEAI c "10".
- MEAI casNumber "73305".
- MEAI chemspiderid "11591017".
- MEAI h "13".
- MEAI hasPhotoCollection MEAI.
- MEAI iupacName "5".
- MEAI legalStatus "Undergoing safety testing".
- MEAI molecularWeight "163.216".
- MEAI n "1".
- MEAI o "1".
- MEAI pubchem "12147687".
- MEAI routesOfAdministration "Oral".
- MEAI synonyms "5".
- MEAI verifiedfields "changed".
- MEAI verifiedrevid "477212458".
- MEAI watchedfields "changed".
- MEAI width "200".
- MEAI wikiPageUsesTemplate Template:Drugbox.
- MEAI wikiPageUsesTemplate Template:Reflist.
- MEAI subject Category:Amines.
- MEAI subject Category:Designer_drugs.
- MEAI subject Category:Drugs_with_unknown_mechanisms_of_action.
- MEAI subject Category:Indanes.
- MEAI hypernym Molecule.
- MEAI type ChemicalCompound.
- MEAI type ChemicalSubstance.
- MEAI type Drug.
- MEAI type ChemicalObject.
- MEAI type Thing.
- MEAI type Q8386.
- MEAI comment "5-Methoxy-2-aminoindane (MEAI, also known as 5-MeO-AI), also called Chaperon, is a psychoactive small molecule belonging to the aminoindanes with a mechanism of action described by one patent as dopamine D3 receptor ligands.It was first prepared by Schering AG in 1956. David Nutt and Amanda Feilding filed a patent application for the drug that is supposed to give people a pleasant intoxication as well as limit the amount they drink.MEAI was available through grey market sources in 2011.".
- MEAI label "MEAI".
- MEAI sameAs m.012krkzg.
- MEAI wasDerivedFrom MEAI?oldid=680657358.
- MEAI depiction 5-Methoxy-2-indanamine.svg.
- MEAI isPrimaryTopicOf MEAI.